Karen T. Putnam

Cerebrospinal fluid β-amyloid1–42 and tau in control subjects at risk for Alzheimer’s disease: The effect of APOE ε4 allele

Holly Soares, Trey Sunderland, Gyorgy Csako, 2004, Biological Psychiatry.

Decreased-Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

Trey Sunderland, J. Bartko, T. Sunderland, 2003 .

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

Jordan Grafman, J. Grafman, E. Huey, 2006, Neurology.